Harrison Daron B, Phillips Alisa L, Tansey James B, Clarke Travis J, Wood C B, Nedzi Lucien, Schwartz David L, Makowski Liza, Hayes D N, Newman Grace, Gleysteen John P
Department of Otolaryngology-Head & Neck Surgery, University of Tennessee Health Science Center College of Medicine, Memphis, Tennessee, U.S.A.
Department of Otolaryngology-Head & Neck Surgery, Oregon Health & Science University, Portland, Tennessee, U.S.A.
Laryngoscope. 2025 Feb;135(2):741-743. doi: 10.1002/lary.31815. Epub 2024 Oct 7.
To report a case of a patient undergoing GLP-1 receptor agonist therapy in which increased FDG uptake in brown adipose tissue (BAT) mimicked metastatic head and neck cancer on PET/CT imaging. A 61-year-old female with Class III obesity presented with a right-sided neck mass after significant weight loss following the use of the GLP-1 receptor agonist, Semaglutide. PET/CT revealed FDG uptake in the right level II lymph node and extensive BAT uptake throughout the neck and mediastinum, complicating the diagnosis. Increased FDG uptake in the cervical and supraclavicular BAT regions led to diagnostic confusion, mimicking diffuse regional metastasis. Careful interpretation of PET/CT imaging, with fusion of anatomical and functional data, was essential to differentiate hypermetabolic BAT from malignant disease. Increased BAT FDG uptake, particularly in patients using GLP-1 receptor agonists, can complicate the evaluation of head and neck cancer. Awareness of this interaction is critical to avoid misdiagnosis and overtreatment. Laryngoscope, 135:741-743, 2025.
报告一例接受胰高血糖素样肽-1(GLP-1)受体激动剂治疗的患者,其棕色脂肪组织(BAT)中氟代脱氧葡萄糖(FDG)摄取增加,在正电子发射断层扫描/计算机断层扫描(PET/CT)成像上酷似转移性头颈癌。一名61岁的III级肥胖女性在使用GLP-1受体激动剂司美格鲁肽后体重显著减轻,出现右侧颈部肿块。PET/CT显示右侧II区淋巴结有FDG摄取,且整个颈部和纵隔有广泛的BAT摄取,使诊断变得复杂。颈部和锁骨上BAT区域FDG摄取增加导致诊断混淆,酷似弥漫性区域转移。仔细解读PET/CT成像,融合解剖学和功能数据,对于区分代谢活跃的BAT和恶性疾病至关重要。BAT中FDG摄取增加,尤其是在使用GLP-1受体激动剂的患者中,会使头颈癌的评估变得复杂。认识到这种相互作用对于避免误诊和过度治疗至关重要。《喉镜》,135:741 - 743,2025年。